![]() |
![]() |
Teisinis statusas
Patentas galioja
(51) | INT.CL. | C07D 407/12 | (2006.01) |
C07D 309/10 | (2006.01) | ||
A61K 31/351 | (2006.01) | ||
A61P 3/10 | (2006.01) |
(11) | Patento numeris | 2187742 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 08798514.9 |
Europos patento paraiškos padavimo data | 2008-08-22 | |
(97) | Europos patento paraiškos paskelbimo data | 2010-05-26 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2017-10-25 |
(46) | Apibrėžties vertimo paskelbimo data | 2018-01-10 |
(86) | Numeris | PCT/US2008/074058 |
Data | 2008-08-22 |
(87) | Numeris | WO 2009/026537 |
Data | 2009-02-26 |
(30) | Numeris | Data | Šalis |
957625 P | 2007-08-23 | US |
(72) |
SONG, Yanli, CN
CHEN, Yuanwei, US
CHENG, Huawei, CN
LI, Shengbin, CN
WU, Yuelin, CN
FENG, Yan, US
LV, Binhua, CN
XU, Baihua, CN
SEED, Brian, US
HADD, Michael J., US
DU, Jiyan, CN
WANG, Congna, CN
ROBERGE, Jacques Y., CN
|
(73) |
Theracos Sub, LLC,
225 Cedar Hill Street, Suite 200, Marlborough, MA 01752,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | (2S,3R,4R,5S,6R)-2-(4-chlor-3-benzilfenil)-6-(hidroksimetil)tetrahidro-2H-piran-3,4,5-triolio dariniai, skirti panaudoti diabeto gydymui |
(2S,3R,4R,5S,6R)-2-(4-CHLORO-3-BENZYLPHENYL)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL DERIVATIVES FOR USE IN THE TREATMENT OF DIABETES |
Mokėjimo data | Galiojimo metai | Suma | |
2024-07-18 | 17 | 347.00 EUR |
2025-08-22 |